Literature DB >> 19393775

Accumulation of oxidative stress around the stroke-like lesions of MELAS patients.

Yuri Katayama1, Kengo Maeda, Takahiro Iizuka, Masaharu Hayashi, Yoshio Hashizume, Mitsuru Sanada, Hiromichi Kawai, Atsunori Kashiwagi.   

Abstract

To investigate the relationship between oxidative stress and progressive spread of the stroke-like lesions in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with 3243A>G mutation, we retrospectively analyzed the spread frequency in patients with and without treatment with the radical scavenger edaravone. Oxidative damage and defensive enzymes were histologically evaluated. Spread was significantly less frequent in the patients treated with edaravone. Although 8-hydroxy-2'-deoxyguanosine, a marker for oxidative damage of DNA, was obviously accumulated in peri-lesional surviving neurons, manganese superoxide dismutase and 8-oxoguanine glycosylase 1 were not up-regulated in those neurons. Increased oxidative stress and insufficient defense could be involved in the pathogenesis of the spreading lesions in MELAS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393775     DOI: 10.1016/j.mito.2009.04.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  14 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

2.  Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy.

Authors:  Z Liu; D Zheng; X Wang; J Zhang; S Xie; J Xiao; X Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 3.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

Review 4.  MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.

Authors:  Ying-Han R Hsu; Haran Yogasundaram; Nirmal Parajuli; Lucas Valtuille; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

5.  The appearance of ADCs in the non-affected areas of the patients with MELAS.

Authors:  Zhenghua Liu; Xiwei Liu; Lihong Hui; Danhua Zhao; Xiaoying Wang; Sheng Xie; Jiangxi Xiao; Xuexiang Jiang
Journal:  Neuroradiology       Date:  2010-06-17       Impact factor: 2.804

Review 6.  Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome.

Authors:  Shi-Bei Wu; Yi-Shing Ma; Yu-Ting Wu; Yin-Chiu Chen; Yau-Huei Wei
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

7.  Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations.

Authors:  Hiroki Kobayashi; Hideyuki Hatakeyama; Haruna Nishimura; Mutsumi Yokota; Sadafumi Suzuki; Yuri Tomabechi; Mikako Shirouzu; Hiroyuki Osada; Masakazu Mimaki; Yu-Ichi Goto; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2020-11-09       Impact factor: 15.040

8.  Humanin: a mitochondrial signaling peptide as a biomarker for impaired fasting glucose-related oxidative stress.

Authors:  Annet Voigt; Herbert F Jelinek
Journal:  Physiol Rep       Date:  2016-05

9.  Quantitative measurement of cerebral oxygen extraction fraction using MRI in patients with MELAS.

Authors:  Lei Yu; Sheng Xie; Jiangxi Xiao; Zhaoxia Wang; Xiaodong Zhang
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.